Joe Bonaccorso - Aug 24, 2023 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
Chief Commercial Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
VRCA
Transactions as of
Aug 24, 2023
Transactions value $
$0
Form type
4
Date filed
8/28/2023, 04:37 PM
Previous filing
Jul 25, 2023
Next filing
Nov 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Award $0 +62.5K +99.62% $0.00 125K Aug 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of shares of common stock underlying performance stock units resulting from the achievement of certain non-financial milestones. These shares have not been delivered.